The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for ...